Search
Glycogen Synthetase Deficiency
smpdb.ca/view/SMP0000552DiseaseGlycogen storage disease, also called glycogenosis and dextrinosis, is a rare inborn error of metabolism (IEM) and recessive disorder, which is caused by a defective glycogen synthase. … Treatments are also depend on the type of glycogen storage disease.
Drugs: Pyridoxal phosphate · NADH · ATP · Calcium · Magnesium cation · Uridine diphosphate glucose +4 moreEnzymes: Glycogen debranching enzyme, Glycogen phosphorylase, liver formGlycogen Synthetase Deficiency
smpdb.ca/view/SMP0125758DiseaseGlycogen storage disease, also called glycogenosis and dextrinosis, is a rare inborn error of metabolism (IEM) and recessive disorder, which is caused by a defective glycogen synthase. … Treatments are also depend on the type of glycogen storage disease.
Drugs: Pyridoxal phosphate · NADH · ATP · Calcium · Magnesium cation · Uridine diphosphate glucose +4 moreEnzymes: Glycogen debranching enzyme, Glycogen phosphorylase, liver formGlycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease
smpdb.ca/view/SMP0125790DiseaseGlycogen storage disease type 1A (GSD1A), or von Gierke disease, is caused by a defect in the G6PC gene which codes for Glucose-6-phosphatase. … Glycogen storage disease type 1A causes clinically significant end-organ disease with significant morbidity. Usually it presents in childhood.
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease
smpdb.ca/view/SMP0000374DiseaseGlycogen storage disease type 1A (GSD1A), or von Gierke disease, is caused by a defect in the G6PC gene which codes for Glucose-6-phosphatase. … Glycogen storage disease type 1A causes clinically significant end-organ disease with significant morbidity. Usually it presents in childhood.